20 May 2013
Keywords: evotec, acquires, rest, ens, secures, 47m, euros
Article | 14 March 2005
German drug discovery and development firm Evotec OAI AG says it is acquiring the outstanding 78% of Evotec Neurosciences (ENS) that ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
14 March 2005
17 May 2013
© 2013 thepharmaletter.com